[Federal Register: March 18, 1999 (Volume 64, Number 52)] [Notices] [Page 13413] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr18mr99-58] ----------------------------------------------------------------------- DEPARTMENT OF DEFENSE Department of the Navy Government-Owned Inventions Available for Licensing AGENCY: Department of the Navy, DOD. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Department of the Navy hereby gives notice of the general availability of exclusive or partially exclusive licenses under the following pending patents. Any license granted shall comply with 35 USC 209 and 37 CFR Part 404. Applications will be evaluated utilizing the following criteria: (1) Ability to manufacture and market the technology; (2) manufacturing and marketing capability; (3) time required to bring technology to market and production rate; (4) royalties; (5) technical capabilities; (6) Small business status. Serial No. 60/101001 entitled ``Intestinal Hydrogen Removal Using Hydrogen-metabolizing Microbes,'' dated September 18, 1998; Serial No. 08/595688 entitled ``Rapid Immunoassay for Periodontopathic Bacteria,'' dated February 2, 1996; Serial No. 09/ 044214 entitled ``Rapid Immunoassay to Detect Infection With Mycobacterium tuberculosis,'' dated November 27, 1995; Serial No. 08/766203 entitled ``Rapid Immunoassay for Cariogenic Bacteria,'' dated December 12, 1996; Serial No. 07/583170 entitled ``Rapid Microbial Protease Assay,'' dated January 4, 1996; Serial No. 08/ 556391 entitled ``Method and System for Removing Mercury From Dental Waste Water,'' dated December 1, 1995; Serial No. 08/048042 entitled ``Transgenic Mouse Expressing T Lymphocyte Activating Molecule, B7, on Pancreatic Beta Cells,'' dated February 17, 1994; Serial No. 82,004 entitled ``Composition and Method to Prevent Graft Rejection and Other Counter Adaptive T Lymphocyte Mediated Immune Responses,'' dated June 11, 1997; Serial No. 60/077104 entitled ``PKC-mediated Dendritic Cell Differentiation Pathway,'' dated March 6, 1998; Serial No. 60/049389 entitled ``Blocking the Rejection of an Allograft Using the Combination of CD28 Pathway Blocker (CTLAY-Ig) and Anti-CD40L, in Primates,'' dated June 11, 1997; Serial No. 08/ 587609 entitled ``Murine Hybridoma and Antibody Binding to CD28 Receptor Secreted by the Hybridoma and Method of Using the Antibody,'' dated January 17, 1996; Serial No. 82011 entitled ``Human Brain Vascular Endothelial Cell Growth Medium and Method for Expansion of Primitive CD34+,CD38-Bone Marrow Stem Cells,'' dated December 4, 1998; Serial No. 08/772,225 entitled ``Use of Oral Interleukin-6 as Therapy for Hemorrhagic Shock,'' dated December 20, 1996; Serial No. 08/671,056 entitled ``Recombinant Fusion Protein Subunit Vaccine Against Dengue Virus Infection,'' dated June 27, 1996; Serial No. 08/053450 Method of Use of Protective Malaria Sporozoite Surface Protein Immunogen and Gene,'' dated September 19, 1997; Serial No. 08/176024 entitled ``Murine Monoclonal Antibodies Protective Against P. vivax Malaria,'' dated September 20, 1996; Serial No. 08/234027 entitled ``Method of Using Interleukin-12 to Provide Protection Against Infection with Malaria,'' dated August 20, 1996; Serial No. 08/000906 entitled ``Pharmaceutical Composition of Esherichia coli Heat-labile Enterotoxin Adjuvant and Methods of Use,'' dated January 6, 1993; Serial No. 09/159568 entitled ``A Method to Preserve Bacteria in a Fully Dehydrated State Without Special Equipment,'' dated September 24, 1998; Serial No. 08/027254 entitled ``Naked DNA Vaccine Against Hepatitis E Virus Infection,'' dated March 18, 1998; Serial No. 78,997 entitled ``CPG Immunostimulatory Motifs For the Prophylaxis of an Treatment for Malaria (P. falciparum, P. vivax, P. ovale and P. malarie),'' dated December 15, 1998; Serial No. 79,092 entitled ``Molecular Analysis of Attenuated Strains of Dengue Virus After Serial Passage in Primary Dog Kidney Cells,'' dated August 21, 1998; Serial No. 60/ 101002 entitled ``The Increase in Seroreactivity of Surface Protein Antigen of typhus Rickettsia Due to Methylation,'' dated September 18, 1998; Serial No. 08/869423 entitled ``PD2ME and p1012D2ME, Dengue-2 Virus DNA Vaccine,'' dated June 4, 1997; Serial No. 60/ 108114 entitled ``Use of Recombinant Flagellin as Campylobacter Vaccine,'' dated July 15, 1997; Serial No. 60/068732 entitled ``Expression and Refolding of the Major Outer Membrane Protein of Orientia tsutsugamushi and Its Use in Enzyme-linked Immunosorbant Assays,'' dated December 24, 1997; Serial No. 09/163,339 entitled ``Diagnostic Monoclonal Antibody for Vibrio cholerae 0139,'' dated September 29, 1997; Serial No. 60/060,558 entitled ``Diagnostic Monoclonal Antibody for Vibrio cholerae 01,'' dated September 17, 1996; Serial No. 60/082,947 entitled ``Method and Process for Establishment of Stage Specific Expression and Characterization of Proteins Based on Microbial or Human Genomic Sequence Data,'' dated April 24, 1998; Serial No. 60/107131 entitled ``Chromosome 2 Sequence of the Human Malaria Parasite Plasmodium falciparum and Proteins of said Chromosome Useful in Anti-Malarial Vaccines and Diagnostic Reagents,'' dated October 30, 1998; Serial No. 08/155888 entitled ``Polynucleotide Vaccine Protective Against Malaria, Methods of Protection and Vector for Delivering Polynucleotide Vaccines,'' dated November 23, 1993; Serial No. 8/917543 entitled ``Rapid Detection and Quantification of Pathogens Using Filter Monitor Technology and Colony Lift Immunoassay,'' dated August 26, 1997; Serial No. 60/069761 entitled ``Prevention or Reversal of Sensorineural Hearing Loss (SNHL) Through Biologic Mechanisms,'' dated July 31, 1998; and Serial No. 08/660000 Ultra-Low Temperature Neck Bonding Process,'' dated May 27, 1997. DATES: Applications for an exclusive or partially exclusive license may be submitted at any time from the date of this notice. ADDRESSES: Naval Medical Research Center, 8901 Wisconsin Ave, Bethesda, MD 20889-5607. FOR FURTHER INFORMATION CONTACT: CDR Charles J. Schlagel, Marketing Director, Naval Medical Research Center, 8901 Wisconsin Ave, Bethesda, MD 20889-5607. Telephone (301) 295-5658. Pamela A. Holden, Lieutenant Commander, Judge Advocate General Corps, U.S. Navy, Federal Register Liaison Officer. [FR Doc. 99-6606 Filed 3-17-99;8:45am] BILLIING CODE 3810-FF-P